MoreBack to News Headlines

Pfizer and Moderna created life-saving vaccines. So why are their stocks crumbling?
CNN
Pfizer, BioNTech and Moderna are experiencing a post-vaccine hangover on Wall Street this year.
All three stocks surged spectacularly in 2021, thanks largely to their Covid-19 vaccines' success and strong sales. But 2022 hasn't been as kind to them. Shares of Pfizer (PFE) are down about 15%, while its Comirnaty vaccine partner BioNTech (BNTX) has fallen 35%. Moderna (MRNA) has fared even worse, plunging more than 40%.
What gives? Sales of the Covid vaccines aren't the problem. Pfizer has said that it expects revenue from Comirnaty, which it splits equally with BioNTech, to hit $32 billion in 2022 while Moderna has forecast that it could generate nearly $20 billion in revenue from its coronavirus shot this year.
More Related News